Les meilleurs doctors en Israël pour votre Transplantation de cellules souches haploidentiques - TOP 14 des médecins

Le Dr Ram Ron est spécialisé en transplantation de cellules souches haplo-identiques au Centre médical Sourasky (Ichilov).

• Plus de 25 ans d'expérience dans ce domaine
• Formation spécialisée (Fellowship) au Ronald O Perelman and Claudia Cohen Centre
• Spécialisé dans les techniques complexes de médecine de la reproduction

Plus de 300 transplantations de cellules souches – Le Dr Ronit El Hasid dirige l'oncohématologie pédiatrique à l'Hôpital pour enfants Dana Dwek, un établissement de référence dans ce domaine.

• Se spécialise dans les greffes de moelle osseuse et de sang de cordon ombilical pour enfants
• A publié 50 articles de recherche et 40 rapports de conférence
• A suivi une formation au City of Hope Hospital de Los Angeles
• Membre de l'Association américaine d'hématologie (American Hematology Association)

Le Dr Ron Ram a réalisé plusieurs centaines de greffes de cellules souches au Centre médical Sourasky, se spécialisant dans les procédures haplo-identiques.

• Certifié (qualifié) en médecine interne, en hématologie et en oncologie médicale
• A effectué un fellowship (internat spécialisé) en hématologie et oncologie au New York Medical College
• A publié plus de 30 articles scientifiques sur l'hématologie et l'oncologie
• A contribué à un chapitre d'un manuel médical

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Le Dr Michael Shapira est spécialisé en Transplantation de Moelle Osseuse au Centre Médical Sourasky (Ichilov), avec une vaste expérience dans les procédures de cellules souches haplo-identiques.

• Diplômé de la Faculté de médecine de l'Université Hébraïque en 1999
• S'est spécialisé en médecine interne au Centre Médical Hadassah
• Médecin senior au département de Transplantation de Moelle Osseuse à Hadassah
• Parle couramment l'anglais et l'hébreu pour la communication avec les patients

Le Dr Dror Levin est spécialisé dans les traitements innovants des troubles sanguins pédiatriques et du cancer des os, se concentrant sur les cas complexes au Centre médical Sourasky.

• Directeur de l'hémato-oncologie pédiatrique au Centre médical Sourasky
• Membre de la Société israélienne d'hématologie-oncologie pédiatrique (ISPHO)
• Formé dans des institutions de premier plan, notamment l'Institut orthopédique Rizzoli en Italie
• Coordonne le traitement du cancer des os (sarcome) chez les enfants

Fort de 31 ans de dévouement à l'onco-hématologie, le Dr Aviv est spécialisé dans les troubles sanguins complexes au Centre médical Sourasky (Clinique Ichilov).

• Spécialisé en transplantation de cellules souches haplo-identiques
• Vaste expérience des cas rares et difficiles
• Exerce dans un centre médical de premier plan en Israël

Expert de premier plan en leucémie lymphoïde chronique – Le Dr Herishanu Yair a reçu de nombreuses distinctions pour ses travaux de recherche et son activité clinique en hématologie.

• Hématologue certifié (board-certified) avec plus de 20 ans d'expérience
• Lauréat du prix d'oncologie Klitzberg de l'American Physician Fellowship
• Membre des associations d'hématologie israélienne et américaine
• Formé dans les meilleurs centres médicaux, notamment le Tel Aviv Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.